Paid Clinical Trials in La Crosse, WI

As of September 2026, 93 paid clinical trials are recruiting in La Crosse, Wisconsin. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

91 clinical trials

Get a weekly email when new trials open in La Crosse, WI.

Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

for Indolent B-Cell Non-Hodgkin Lymphoma

Sites in La Crosse, Eau Claire +5 more locations

Sponsor: Mayo Clinic

Sex: All·Age: 18+

Code: NCT06386315·Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for Grade 3b Follicular Lymphoma

Sites in La Crosse, Eau Claire +97 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT05890352·Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

for Metastatic Malignant Neoplasm in the Brain

Sites in La Crosse, Eau Claire +5 more locations

Sponsor: Mayo Clinic

Sex: All·Age: 18+

Code: NCT05222620·Phase 2·Recruiting·Listed Feb 2022

Apply to this trial

Vitamin D for Prostate Endocrine Therapy

for Stage I Prostate Cancer AJCC v8

Sites in La Crosse, Green Bay +49 more locations

Sponsor: University of Rochester

Sex: Male·Age: 50+

Code: NCT05838716·Phase 3·Recruiting·Listed May 2023

Apply to this trial

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

for Malignant Solid Neoplasm

Sites in La Crosse, Eau Claire +586 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT04871542·Recruiting·Listed May 2021

Apply to this trial

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

for Large B-Cell Lymphoma With IRF4 Rearrangement

Drug: Golcadomide

Sites in La Crosse, Eau Claire +5 more locations

Sponsor: Mayo Clinic

Sex: All·Age: 18+

Code: NCT06834373·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

for Localized Prostate Adenocarcinoma

Sites in La Crosse, Eau Claire +3 more locations

Sponsor: Mayo Clinic

Sex: Male·Age: 18+

Code: NCT06325046·Recruiting·Listed Mar 2024

Apply to this trial

Passive Stretching in Peripheral Arterial Disease Patients

for Peripheral Arterial Disease

1 location in La Crosse

Sponsor: University of Wisconsin, La Crosse

Sex: All·Age: 40 - 90

Code: NCT06420752·Phase 2·Recruiting·Listed May 2024

Apply to this trial

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in La Crosse +26 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 60+

Code: NCT07437950·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma

for Multiple Myeloma

Drug: Belantamab mafodotin

1 location in La Crosse

Sponsor: PrECOG, LLC.

Sex: All·Age: 18 - 79

Code: NCT07285239·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for Endometrial Carcinoma

Sites in La Crosse, Eau Claire +325 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial